GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (SHSE:600671) » Definitions » Interest Expense

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Interest Expense : ¥-7.8 Mil (TTM As of Sep. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hangzhou TianMuShan Pharmaceutical Enterprise Co's interest expense for the three months ended in Sep. 2024 was ¥ -1.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-7.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hangzhou TianMuShan Pharmaceutical Enterprise Co's Operating Income for the three months ended in Sep. 2024 was ¥ 21.2 Mil. Hangzhou TianMuShan Pharmaceutical Enterprise Co's Interest Expense for the three months ended in Sep. 2024 was ¥ -1.1 Mil. Hangzhou TianMuShan Pharmaceutical Enterprise Co's Interest Coverage for the quarter that ended in Sep. 2024 was 19.74. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Interest Expense Historical Data

The historical data trend for Hangzhou TianMuShan Pharmaceutical Enterprise Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Interest Expense Chart

Hangzhou TianMuShan Pharmaceutical Enterprise Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.23 -6.93 -7.35 -7.41 -7.19

Hangzhou TianMuShan Pharmaceutical Enterprise Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.36 -2.51 -1.55 -2.67 -1.08

Hangzhou TianMuShan Pharmaceutical Enterprise Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-7.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou TianMuShan Pharmaceutical Enterprise Co  (SHSE:600671) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Interest Expense for the three months ended in Sep. 2024 was ¥-1.1 Mil. Its Operating Income for the three months ended in Sep. 2024 was ¥21.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was ¥21.3 Mil.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Sep. 2024 )/Interest Expense (Q: Sep. 2024 )
=-1*21.241/-1.076
=19.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (SHSE:600671) » Definitions » Interest Expense
Comparable Companies
SZSE:000952 SZSE:000705 SZSE:001367 SHSE:600613 SZSE:301281 SZSE:002198 SZSE:301096 SZSE:000908 SZSE:301507 SZSE:300006 LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE
Traded in Other Exchanges
N/A
Address
No.18 Shangyang Road, Jinnan Street, Lin'an District, Zhejiang Province, Hangzhou, CHN, 311300
Website
http://www.hztmyy.com
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China. The company is also engaged in medical device production and sales, cosmetics production, sales, production and sales of sanitary products.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Headlines

No Headlines